AirXpanders, Inc. (AXP) reported the publication of a large retrospective clinical study by Chopra, et al. which concluded that the use of AeroForm tissue expanders offers notable advantages for breast reconstruction. According to AirXpander, the paper noted that when employed in the prepectoral space, the AeroForm device may be associated with reduced infection rates and decreased utilization of healthcare and patient resources
http://crweworld.com/article/news-provided-by-pr-newswire/1042654/airxpanders-announces-new-data-demonstrating-reduced-infection-rates-and-decreased-utilization-of-healthcare-resources-associated-with-aeroform
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.1¢ | 0.1¢ | $2.276K | 2.275M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 36646903 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 82664099 | 41 |
View Market Depth
| Last trade - 11.04am 25/07/2025 (20 minute delay) ? |
| AXP (ASX) Chart |